Extracorporeal elimination in acute valproic acid poisoning

References

• Bronstein AC, Spyker DA, Cantilena LRJr, Green JL, Rumack BH, Heard SE. 2007 annual report of the American Association of Poison Control Centers National Poison Data System (NPDS): 25th annual report. Clin Toxicol 2008; 46:927–1057.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Krenzelok EP, Klein-Schwartz W, Winter ML, Weber JA, Sollee DR, Bangh SA, Griffith JR. Multicentre case series of valproic acid ingestion. Serum concentrations and toxicity. Clin Toxicol 2000; 38:755–760.
   Web of Science ®Google Scholar
• Sztajnkrycer MD. Valproic acid toxicity: overview and management. Clin Toxicol 2002; 40:789–795.
   Web of Science ®Google Scholar
• Lheureux PER, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol 2009; 47:101–111.
   PubMed Web of Science ®Google Scholar
• PB Mortensen, Hansen HE, Pedersen B, Hartmann-Andersen F, Husted SE. Acute valproate intoxication: biochemical investigations and hemodialysis treatment. Int J Clin Pharmacol Ther Toxicol 1983; 21:64–68.
   PubMedGoogle Scholar
• Brubacher JR, Dahghani P, McKnight D. Delayed toxicity following ingestion of enteric-coated divalproex sodium (Epival). J Emerg Med 1999; 17:463–467.
   PubMed Web of Science ®Google Scholar
• Johnson LZ, Martinez I, Fernandez MC, Davis CP, Kasinath BS. Successful treatment of valproic acid overdose with hemodialysis. Am J Kidney Dis 1999; 33:786–789.
   PubMed Web of Science ®Google Scholar
• Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR. High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 2000; 34:1146–1151.
   PubMed Web of Science ®Google Scholar
• Hicks LK, McFarlane PA. Valproic acid overdose and haemodialysis. Nephrol Dial Transplant 2001; 16:1483–1486.
   PubMed Web of Science ®Google Scholar
• Kroll P, Nand C. Hemodialysis in the treatment of valproic acid overdose. J Clin Psychiatry 2002; 63:78–79.
   PubMed Web of Science ®Google Scholar
• Kay TD, Playford HR, Johnson DW. Hemodialysis versus continuous venovenous hemodiafiltration in the management of severe valproate overdose. Clin Nephrol 2003; 59:56–58.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Woywodt A, Schumann G, Haller H, Fliser D. Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. Clin Toxicol 2003; 41:873–876.
   Web of Science ®Google Scholar
• Singh SM, McCormick BB, Mustata S, Thompson M, Prasad GV. Extracorporeal management of valproic acid overdose: a large regional experience. J Nephrol 2004; 17:43–49.
   PubMed Web of Science ®Google Scholar
• Meek MF, Broekrolofs J, Yska JP, Egbers PH, Boerma EC, van der Voort PH. Valproic acid intoxication: sense and non-sense of haemodialysis. Neth J Med 2004; 62:333–336.
   PubMed Web of Science ®Google Scholar
• Guillaume CP, Stolk L, Dejagere TF, Kooman JP. Successful use of hemodialysis in acute valproic acid intoxication. Clin Toxicol 2004; 42:335–336.
   Web of Science ®Google Scholar
• Minville V, Roche Tissot C, Samii K. Haemodialysis, l-carnitine therapy and valproic acid overdose. Ann Fr Anesth Reanim 2004; 23:357–360.
   PubMed Web of Science ®Google Scholar
• Eyer F, Felgenhauer N, Gempel K, Steimer W, Gerbitz KD, Zilker T. Acute valproate poisoning. Pharmacokinetics, alteration in fatty acid metabolism and changes during therapy. J Clin Psychopharmacol 2005; 25:376–380.
   Google Scholar
• Mestrovic J, Filipovic T, Polic B, Stricevic L, Omazic A, Kuzmanic-Samija R, Markic J. Life-threatening valproate overdose successfully treated with haemodialysis. Arh Hig Rada Toksikol 2008; 59:295–298.
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Fennell RS3rd, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol 2002; 17:312–315.
   PubMed Web of Science ®Google Scholar
• Van der Merwe AC, Albracht CF, Brink MS, Coetzee AR. Sodium valproate poisoning. A case report. S Afr Med J 1985; 67:735–736.
   PubMed Web of Science ®Google Scholar
• Graudins A, Aaron CK. Delayed peak serum valproic acid in massive divalproex overdose – treatment with charcoal hemoperfusion. J Toxicol Clin Toxicol 1996; 34:335–341.
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Ogawa H, Maeyama R, Okudaira K, Shinka T, Kuhara T, Matsumoto I. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Epilepsia 1997; 38:950–953.
   PubMed Web of Science ®Google Scholar
• Peces R, Fernandez EJ, Sanchez RJ, Peces C, Montero A, Selgas R. Hemoperfusion in the treatment of acute valproic acid intoxication. Nefrologia 2007; 27:370–373.
   PubMed Web of Science ®Google Scholar
• Jung J, Ahn K. A case of hemoperfusion and l-carnitine management in valproic acid overdose. Am J Emerg Med 2008; 26:388.
   PubMed Web of Science ®Google Scholar
• Rahman MH, Haqqie SS, McGoldrick MD. Acute haemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal haemoperfusion. Hemodial Int 2006; 10:256–259.
   PubMedGoogle Scholar
• Meyer S, Kuhlman MK, Peters FT, Limbach HG, Lindinger A. Severe valproic acid intoxication is associated with atrial tachycardia: secondary detoxication by hemoperfusion. Klin Padiatr 2005; 217:82–85.
   PubMed Web of Science ®Google Scholar
• Roodhooft AM, Van Dam K, Haentjens D, Verpooten GA, Van Acker KJ. Acute sodium valproate intoxication: occurrence of renal failure and treatment with haemoperfusion-haemodialysis. Eur J Pediatr 1990; 149:363–364.
   PubMed Web of Science ®Google Scholar
• Tank JE, Palmer BF. Simultaneous “in series” hemodialysis and hemoperfusion in the management of valproic acid overdose. Am J Kidney Dis 1993; 22:341–344.
   PubMed Web of Science ®Google Scholar
• Fernandez MC, Walter FG, Kloster JC, Do SM, Brady LA, Villarin A, Ruffenach SJ, Prosnitz EH, Salmon JV. Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. Vet Hum Toxicol 1996; 38:438–443.
   PubMedGoogle Scholar
• Franssen EJ, van Essen GG, Portman AT, de Jong J, Go G, Stegeman CA, Uges DR. Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 1999; 21:289–292.
   PubMed Web of Science ®Google Scholar
• Al Aly Z, Yalamanchili P, Gonzalez E. Extracorporeal management of valproic acid toxicity: a case report and review of the literature. Semin Dial 2005; 18:62–66.
   PubMed Web of Science ®Google Scholar
• Van den Broek MPH, Sikma MA, Ververs TF, Meulenbelt J. Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination. Eur J Emerg Med 2009; May 6 (Epub).
   Web of Science ®Google Scholar
• van Keulen JG, van Wijk JA, Touw DJ, van der Deure J, Markhorst DG, Gemke RJ. Effectiveness of haemofiltration in valproic acid intoxication. Acta Paediatr 2001; 90:958–959.
   PubMed Web of Science ®Google Scholar
• Khan E, Huggan P, Celi L, MacGinley R, Schollum J, Walker R. Sustained low-efficiency dialysis with filtration (SLEDD-f) in the management of acute sodium valproate intoxication. Hemodial Int 2008; 12:211–214.
   PubMed Web of Science ®Google Scholar
• Minari M, Maggiore U, Tagliavini D, Rotelli C, Cabassi A, David S, Fiaccadori E. Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion. Ann Emerg Med 2002; 39:204–205.
   PubMed Web of Science ®Google Scholar
• Klotz U, Antonin KH. Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 1977; 21:736–743.
   PubMed Web of Science ®Google Scholar
• Dupuis RE, Lichtman SN, Pollack GM. Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites. Drug Saf 1990; 5:65–71.
   Google Scholar
• Zaccara G, Messori A, Moroni F. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1988; 15:367–389.
   PubMed Web of Science ®Google Scholar
• Bowdle AT, Patel IH, Levy RH, Wilensky AJ. Valproic acid dosage and plasma protein binding and clearance. Clin Pharmacol Ther 1980; 28:486–492.
   PubMed Web of Science ®Google Scholar
• Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 2006; 19:402–407.
   PubMed Web of Science ®Google Scholar
• Gwilt PR, Perrier D. Plasma protein binding and distribution characteristics of drugs as indices of their haemodialyzability. Clin Pharmacol Ther 1978; 24:154–161.
   PubMed Web of Science ®Google Scholar
• Garella S. Extracorporeal techniques in the treatment of exogenous intoxications. Kidney Int 1988; 33:735–754.
   PubMed Web of Science ®Google Scholar
• Kandrotas RJ, Love JM, Gal P, Oles KS. The effect of hemodialysis and hemoperfusion on serum valproic acid concentration. Neurology 1990; 40:1456–1458.
   PubMed Web of Science ®Google Scholar
• Marbury TC, Lee CS, Bruni J, Wilder BJ. Hemodialysis of valproic acid in uraemic patients. Dial Transplant 1980; 9:961–964.
   Web of Science ®Google Scholar
• Gubensek J, Buturovic-Ponikvar J, Ponikvar R, Cebular B. Hemodiafiltration and high-flux hemodialysis significantly reduce serum valproate levels inducing epileptic seizures: case report. Blood Purif 2008; 26:379–380.
   PubMed Web of Science ®Google Scholar
• Churchwell MD, Pasko DA, Smoyer WE, Mueller BA. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 2009; 24:231–238.
   PubMed Web of Science ®Google Scholar
• Rajpoot DK, Gargus JJ. Acute haemodialysis for hyperammonaemia in small neonates. Pediatr Nephrol 2004; 19:390–395.
   PubMed Web of Science ®Google Scholar
• Tsai MF, Chen CY. Valproate-induced hyperammonaemic encephalopathy treated by haemodialysis. Ren Fail 2008; 30:822–824.
   PubMed Web of Science ®Google Scholar